Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus
This study aims to determine the levels of Nε-(carboxymethyl)lysine (CML) in patients with Type 2 diabetic patients with and without ischemic heart disease (IHD) and to find for a possible association between circulating CML and a number of clinical parameters including lipids, hemoglobin A1c (HbA1c...
Main Authors: | Ahmed, Khaled A., Muniandy, Sekaran, Ismail, Ikram Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
The Society for Free Radical Research Japan
2007
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/7223/1/Ahmed-2007-Role_of_N-epsilon-%28C.pdf |
Similar Items
-
Evaluation of Nε-(carboxymethyl)lysine and lipid peroxidation in multiethnic Malaysian subjects with type 2 diabetes mellitus
by: Ismail, I.S., et al.
Published: (2011) -
Nε-(carboxymethyl) lysine and corony atherosclerosis-associated low density lipoprotein abnormalities in type 2 diabetes: current status
by: Ismail, I.S., et al.
Published: (2009) -
Evaluation of N ε-(carboxymethyl)lysine and lipid peroxidation in multiethnic Malaysian subjects with type 2 diabetes mellitus
by: Ahmed, K.A.A., et al.
Published: (2011) -
N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.
by: Ahmed, K.A., et al.
Published: (2009) -
Is F-2-isoprostane a biological marker for the early onset of type 2 diabetes mellitus?
by: Kaviarasan, Subramanian, et al.
Published: (2010)